Homepage
Open in app
Sign in
Get started
Tagged in
Healthcare
Lazarus AI
Lazarus applies AI and computer vision to develop products and custom solutions to optimize process
More information
Followers
19
Elsewhere
More, on Medium
Healthcare
Jessica Pyhtila
in
Lazarus AI
Mar 10, 2022
FDA Approves Combination Treatment for BPH Symptoms
Read more…
1
Jessica Pyhtila
in
Lazarus AI
Feb 17, 2022
FDA Approves New Orally Disintegrating Dosage Form of Glycopyrrolate
Read more…
2
Jessica Pyhtila
in
Lazarus AI
Jan 31, 2022
FDA Approves Novel PCSK9 Inhibitor Inclisiran (Leqvio)
Read more…
Jessica Pyhtila
in
Lazarus AI
Dec 28, 2021
FDA Approves Rivaroxaban in an Oral Suspension Dosage Form
Read more…
2
Jessica Pyhtila
in
Lazarus AI
Oct 12, 2021
FDA Approves Atogepant As Newest CGRP Antagonist for Migraine Prevention
Read more…
Jessica Pyhtila
in
Lazarus AI
Oct 7, 2021
FDA Approves Ergot-Derivative Nasal Spray to Treat Acute Migraine
Read more…
10
Jessica Pyhtila
in
Lazarus AI
Oct 5, 2021
Fatal Opioid Overdoses Skyrocket During COVID-19 Lockdowns
Read more…
1
Jessica Pyhtila
in
Lazarus AI
Oct 1, 2021
Screening Colonoscopy Best Practices Released
By Jessica Pyhtila, PharmD, BCGP, BCPS
Read more…
1
Jessica Pyhtila
in
Lazarus AI
Sep 29, 2021
Using Short and Long-Acting Insulin Together Does Not Increase Cardiovascular Events or Mortality
Read more…
Jessica Pyhtila
in
Lazarus AI
Sep 27, 2021
Treatment Guidelines Released For Cancer Pain
By Jessica Pyhtila, PharmD, BCGP, BCPS
Read more…
10